CN210785891U

CN210785891U - Insomnia therapeutic instrument

Info

Publication number: CN210785891U
Application number: CN201920503925.6U
Authority: CN
Inventors: 周玮欣; 张唤唤; 陈畅明; 刘柏汝
Original assignee: Individual
Current assignee: Guangzhou University of Traditional Chinese Medicine
Priority date: 2019-04-12
Filing date: 2019-04-12
Publication date: 2020-06-19
Anticipated expiration: 2029-04-12

Abstract

The utility model provides an insomnia therapeutic instrument relates to the electronic product field. An insomnia therapeutic apparatus comprises a sleep drug releasing component and a sleep music playing component. The sleep drug releasing component and the sleep music playing component are matched with each other to achieve the effect of treating insomnia. The environment and atmosphere created by the use of the two can achieve the effect of treating insomnia. The drug environment (aromatherapy) created by the sleep drug release assembly is relatively durable, and when a user falls asleep, the drug environment does not cause any psychological burden to the user and does not cause any additional influence to the user, so that the user can absorb the drugs in an extremely natural and comfortable environment. The music (five-tone therapy) which is played by the sleep music playing component and is helpful for promoting sleep and the surrounding medicine environment are matched to achieve more remarkable effect of treating insomnia.

Description

Insomnia therapeutic instrument

Technical Field

The utility model relates to an electronic product field particularly, relates to an insomnia therapeutic instrument.

Background

Insomnia refers to the inability to fall asleep or to remain asleep, also known as sleep-inducing and sleep-sustaining disorders. With the acceleration of life rhythm, the incidence rate of insomnia rises year by year, and the occurrence of insomnia seriously affects the life regularity and the life quality of people. Long-term insomnia can cause listlessness, dysphoria and even psychonosema. Modern medicine generally adopts the treatment of Chinese and western medicine, and western medicine generally adopts the treatment of medicines such as tranquilization, although the curative effect is better, the side effect is larger. The oral administration of traditional Chinese medicine generally has the disadvantages of long course of treatment and slow effect, and causes patients to have a sense of dislike the traditional Chinese medicine. In recent years, more and more scholars are keen to search for new, easy and safe adjunctive or alternative solutions to treat insomnia.

SUMMERY OF THE UTILITY MODEL

An object of the utility model is to provide an insomnia therapeutic instrument, it has the function of treatment insomnia, and the treatment process is simple and safe.

The embodiment of the utility model is realized like this:

an insomnia therapeutic apparatus comprises a sleep drug release component and a sleep music playing component, wherein the sleep drug release component and the sleep music playing component are matched with each other to achieve the effect of treating insomnia.

In some embodiments of the present invention, the sleep music playing component comprises a single chip microcomputer, and the single chip microcomputer is used for controlling the sleep drug releasing component to be started or closed; the singlechip is used for controlling the start or the close of the sleep music playing component.

In some embodiments of the utility model, the sleep drug release subassembly includes the ultrasonic nebulizer, and the ultrasonic nebulizer is used for atomizing the liquid medicine of storage in it.

In some embodiments of the present invention, the ultrasonic nebulizer comprises a cartridge for storing the drug, the cartridge being configured with a feed tube, the feed tube being configured with a feed valve.

In some embodiments of the present invention, the feed valve is a check valve.

The utility model discloses an in some embodiments, ultrasonic nebulizer disposes the level sensor who is used for detecting liquid medicine surplus in the liquid medicine box, and the singlechip controls ultrasonic nebulizer start-up warning or closes the warning according to level sensor's testing result.

In some embodiments of the utility model, the insomnia therapeutic apparatus further comprises an illumination sensor, and the single chip microcomputer controls the start or the close of the sleep drug release assembly according to the detection result of the illumination sensor.

In some embodiments of the present invention, the sleep music playing component includes a speaker.

The utility model discloses an in some embodiments, insomnia therapeutic instrument still includes the casing, and the casing is provided with the display screen, and the display screen is used for the liquid level information of liquid medicine surplus and the broadcast song information of sleep music broadcast subassembly in display time, date, the sleep medicine release subassembly, and sleep music broadcast subassembly all is located the casing.

In some embodiments of the present invention, the drug released by the sleep drug releasing component comprises acorus gramineus, and the music stored by the sleep music playing component comprises songs of horn, plectrum, uterus, quotient, and quince.

The embodiment of the utility model provides an at least, have following advantage or beneficial effect:

the embodiment of the utility model provides an insomnia therapeutic instrument, it mainly includes sleep medicine release subassembly and sleep music broadcast subassembly. The sleep drug releasing component and the sleep music playing component are matched with each other to achieve the effect of treating insomnia. It should be noted that the two components are not limited to be used together, but they may be used separately in different time periods, or the sleep music playing component may be always in a playing state, and the sleep drug releasing component starts to release the drug only under the preset condition of every day. The environment and atmosphere created by the use of the two can achieve the effect of treating insomnia. The medicine released by the sleep medicine releasing component is common medicine which is in accordance with the regulation of pharmacopoeia and has the effects of sedation and hypnosis. The medicine is generally diffused to the surrounding environment in a gaseous state, so that the discomfort of a user caused by the diffusion of the medicine in other states is avoided, and the user can rapidly absorb the medicine in the environment through the respiratory tract, the skin penetration and the like. Of course, the release of the drug should not be too much, and the release duration and the release times can be controlled appropriately according to the order. The medicine environment that the sleep medicine release assembly built is comparatively lasting, and the user is when falling asleep, and the medicine environment can not cause any psychological burden for the user, can not cause any additional influence for the user, makes the user absorb the medicine in extremely natural, comfortable environment, compares other treatment methods, and this kind of mode lets the user accept more easily, can not let the user produce the psychology of borying, also can not have the side effect. The music which is played by the sleep music playing component and is helpful for promoting sleep and the surrounding medicine environment are combined, so that the effect of treating insomnia achieved by the cooperation of the music and the medicine environment is more remarkable.

Drawings

In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are required to be used in the embodiments will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present invention, and therefore should not be considered as limiting the scope, and for those skilled in the art, other related drawings can be obtained according to the drawings without inventive efforts.

FIG. 1 is a schematic structural view of an insomnia therapeutic apparatus provided by an embodiment of the present invention;

FIG. 2 is a schematic view of the internal structure of the insomnia therapeutic apparatus provided by the embodiment of the present invention;

FIG. 3 is a schematic front view of an insomnia therapeutic apparatus according to an embodiment of the present invention;

fig. 4 is a main control circuit diagram of the single chip microcomputer provided by the embodiment of the present invention;

fig. 5 is a circuit diagram of an LCD module of the IIC protocol according to an embodiment of the present invention;

fig. 6 is a circuit diagram of an analog-to-digital conversion module of PCF8591 according to an embodiment of the present invention;

fig. 7 is a circuit diagram of an ultrasonic atomization module provided in an embodiment of the present invention;

fig. 8 is a circuit diagram of a liquid level sensor module according to an embodiment of the present invention;

fig. 9 is a circuit diagram of a voice module of a sleep music playing module according to an embodiment of the present invention;

FIG. 10 is a general circuit diagram of an insomnia therapeutic apparatus provided by an embodiment of the present invention;

fig. 11 is a flow chart of the use design of the insomnia therapeutic apparatus provided by the embodiment of the present invention.

Icon: 100-insomnia treatment apparatus; 102-a single chip microcomputer; 104-liquid crystal display screen; 106-an illumination sensor; 107-USB socket; 108-electric quantity prompting lamp group; 110-a sleep drug release assembly; 111-an atomizing sheet; 112-liquid medicine box; 113-an atomizing tube; 114-a feed pipe; 116-a feed inlet; 117-sealed shell; 118-a spray outlet; 150-a sleep music playing component; 152-a loudspeaker; 180-a housing; 182-a switch button; 184-function buttons; 186-earphone jack.

Detailed Description

In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are some, but not all, embodiments of the present invention. The components of embodiments of the present invention, as generally described and illustrated in the figures herein, may be arranged and designed in a wide variety of different configurations.

Thus, the following detailed description of the embodiments of the present invention, presented in the accompanying drawings, is not intended to limit the scope of the invention, as claimed, but is merely representative of selected embodiments of the invention. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative efforts belong to the protection scope of the present invention.

It should be noted that: like reference numbers and letters refer to like items in the following figures, and thus, once an item is defined in one figure, it need not be further defined and explained in subsequent figures.

In the description of the embodiments of the present invention, it should be noted that, if the terms "center", "upper", "lower", "left", "right", "inner", "outer" and the like indicate the position or positional relationship based on the position or positional relationship shown in the drawings, or the position or positional relationship which is usually placed when the products of the present invention are used, the description is only for convenience of description, and the description is simplified, but the indication or suggestion that the indicated device or element must have a specific position, be constructed in a specific position, and be operated, and thus, the present invention should not be construed as being limited. Furthermore, the terms "first," "second," "third," and the like are used solely to distinguish one from another and are not to be construed as indicating or implying relative importance.

In the description of the embodiments of the present invention, it should be further noted that unless explicitly stated or limited otherwise, the terms "disposed," "mounted," "connected," and "connected" should be interpreted broadly, and may be, for example, fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present invention can be understood according to specific situations by those skilled in the art.

Examples

Referring to fig. 1 and 2, fig. 1 is a schematic structural diagram of an insomnia treatment apparatus 100, and fig. 2 is a schematic internal structural diagram of the insomnia treatment apparatus 100.

The present embodiment provides an insomnia therapeutic apparatus 100, which mainly comprises a sleep drug releasing component 110 and a sleep music playing component 150. The sleep drug releasing assembly 110 and the sleep music playing assembly 150 are used in cooperation with each other to achieve the effect of treating insomnia.

It should be noted that the two "cooperating" are not limited to that the two components are used simultaneously, but they may be used separately in different time periods, or the sleep music playing component 150 may be always in the playing state, and the sleep drug releasing component 110 starts to release the drug only under the preset condition of every day. The environment and atmosphere created by the use of the two can achieve the effect of treating insomnia. The drugs released by the sleep drug releasing assembly 110 are common drugs having sedative and hypnotic effects in compliance with pharmacopoeia regulations. The medicine is generally diffused to the surrounding environment in a gaseous state, so that the discomfort of a user caused by the diffusion of the medicine in other states is avoided, and the user can rapidly absorb the medicine in the environment through the respiratory tract, the skin penetration and the like. Of course, the release of the drug should not be too much, and the release duration and the release times can be controlled appropriately according to the order. The drug environment created by the sleep drug release assembly 110 is relatively persistent, and when a user falls asleep, the drug environment does not cause any psychological burden to the user, and does not cause any additional influence to the user, so that the user can absorb the drugs in an extremely natural and comfortable environment. The music played by the sleep music playing component 150 and helpful for promoting sleep and the surrounding medicine environment are combined, so that the effect of treating insomnia achieved by combining the music and the medicine environment is more remarkable.

In this embodiment, the drug released by the sleep drug releasing assembly 110 includes acorus gramineus. The music stored by the sleep music playing component 150 includes the songs of horn, dog, palace, quotient, and feather five tones. Aromatherapy is performed using sleep drug releasing component 110 and pentatonic therapy is performed using sleep music playing component 150.

Aromatherapy is a method of improving the circulation and endocrine of the human body by using the special properties of drugs having aromatic qi. Modern researches find that most of aromatic traditional Chinese medicines are small molecular substances, can be quickly absorbed by organisms, have the effects of guiding drugs upwards and inducing resuscitation, have a bidirectional regulation effect on a central nervous system, balance brain excitation and inhibition, enable the functions of the central nervous system to tend to be balanced, calm and sleep, and refresh brain and induce resuscitation. The traditional Chinese medicine pharmacology indicates that aromatic drugs are absorbed into a human body through channels, collaterals, acupuncture points, skin, mucous membranes and other ways, and play roles in balancing yin and yang, opening striae, freeing lung and defensive qi, and activating blood and dissolving stasis. For a long time, people seek natural plant Chinese herbal medicines to realize the desire of replacing the current chemical synthetic medicines with natural hypnotic medicines, thereby achieving the purpose of safer and more obvious treatment. Research results in recent years show that many aromatic traditional Chinese medicines have good sedative-hypnotic effect and few adverse reactions, and are worthy of being deeply developed and researched. A large number of researches show that some aromatic medicines in the traditional Chinese medicine can regulate the balance of yin and yang of the organism of a patient to a certain extent and improve the sleep quality. Therefore, in this embodiment, the drug released by the sleep drug releasing component 110 is selected from essential oils extracted from different parts (such as flowers, leaves, seeds, resins, roots, fruits, etc.) of various aromatic plants in nature, and compatibility between therapeutic effects and volatilization speed of the aromatic are required to be considered when different essential oils are formulated.

The grassleaf sweelflag rhizome is the dried rhizome of a perennial herb grassleaf sweelflag rhizome in Araceae, is pungent and warm in taste and aromatic in gas, has the effects of inducing resuscitation and eliminating phlegm, refreshing mind and benefiting intelligence, and resolving dampness and harmonizing stomach, and is used for treating coma, epilepsy, amnesia, insomnia, tinnitus, deafness, epigastric fullness, no hunger and vomiting and diarrhea.

The liquid medicine used in this example can be prepared in the following manner:

weighing a certain amount of rhizoma acori graminei medicinal material, performing reflux extraction for 3 times by adopting ethanol with the purity of 90%, combining extracting solutions for 3 times, heating and concentrating the extracting solutions until no alcohol smell exists, filtering, drying a precipitate part under reduced pressure, performing reflux extraction for 3 times by using petroleum ether, combining the petroleum ether extracting solutions, recovering a solvent until the solvent is dried to obtain the rhizoma acori graminei volatile oil extract, dissolving the extract by using analytically pure methanol, performing filtration by using a 0.45-micron microporous membrane, performing sample injection for 200 mu L, receiving fractions according to a chromatogram, performing purity detection by adopting an HPLC area normalization method on the obtained fractions, performing separation and purification by adopting semi-preparative liquid chromatography, wherein a methanol-water system is used as a mobile phase by adopting the liquid chromatogram, and the result shows that the higher methanol ratio, the shorter retention time of α -asarone and β -asarone can shorten the preparation period of the two products, but the undersize separation degree of the two products is reduced, the separation degree of the methanol ratio can be improved, but the preparation period of the products is prolonged, the preparation cost is increased, the separation effect is also influenced by the same volume, the product is caused by the production, the flat head separation is caused, the separation time is caused by the reduction of the preparation of the methanol-water, when the sample injection time is equal to reach 200 mu L, and the final sample injection time is equal to equal.

The asarin is an insoluble medicine with extremely high fat solubility, the bioavailability of the asarin is very low due to the fact that the solubility of the asarin is too low, only (5.6 +/-1.6)% is reported according to research, the bioavailability of the asarin is improved by a method for increasing the solubility of the medicine, HD (isomeric hexadecyl alkane) is selected as a solubilizer of the asarin by a solubilizing, dissolving assisting or dissolving-latent method in the early stage experiment, the effect of the cosolvent and a surfactant is more satisfactory when the cosolvent and the surfactant are used, the influence of the stability of the asarin solution and the sterilization process on the content of the asarin is used as indexes, the HD (isomeric hexadecyl alkane) is selected as the solubilizer of the asarin, the early stage experiment proves that when the concentration of the HD is 1%, the asarin is incompletely dissolved, the content is greatly reduced after sterilization, when the concentration is increased to 2% -4%, the difference of the asarin after sterilization is not large, the experiment cost problem is considered, the HD is finally selected as the mass percentage concentration of the 2%, after the solubilizer is selected, the proper antioxidant and the chelating agent is further selected to screen the proper antioxidant and further reduce the recovery rate of the asarin in the adjuvant of the adjuvant in the antiseptic in a water, the pH of a proper range of a pH 2-4%, the adjuvant, the pH of the adjuvant is selected by the experiment, the pH of the adjuvant, the pH of the adjuvant, the adjuvant is selected by the experiment, the pH of the experiment, the.

The preparation method of the asarone liquid for direct use comprises the following steps:

① sodium sulfite (400mg), EDTA-2Na (10mg) and sodium chloride (8.74g) in prescribed amounts were dissolved in 30% water for injection, and mixed to obtain solution 1.

② dissolving accurately weighed asarone (160mg) in propylene glycol (30g), stirring in water bath at 60 deg.C to dissolve, adding HD (20g), stirring to dissolve, and mixing to obtain solution 2.

③ pouring solution 1 into solution 2, magnetically stirring at high speed for about 10min, adding and continuously stirring, measuring pH, controlling pH within 6.0-7.5, adding water for injection to full dose, adding 0.05% active carbon, shaking at room temperature for about half an hour, filtering with 0.45um microporous membrane, fine filtering, bottling in 100ml infusion bottle, sealing with gland, sterilizing at 121 deg.C for 30 min, lamp inspecting, labeling, and packaging to obtain medicinal liquid capable of being directly filled into sleep medicine release assembly 110.

We trial-produce three batches of samples, and respectively detect the indexes of the sample, such as clarity, pH, insoluble particles, content, related substances, sterility, bacterial endotoxin and the like, and the results show that all indexes of the sample accord with the related regulations of pharmacopoeia.

The five-tone therapy of the traditional Chinese medicine is to use the traditional yin-yang five-element theory of the traditional Chinese medicine to make the five internal organs of the liver, heart, spleen, lung and kidney correspond to five tones and treat diseases by using five tones of horn, dawn, uterus, Shang and Yu. "Lingshu & evil spirits guests" day: "five sounds in the sky, five zang organs in the body; six laws are in the world, and six fu organs exist in the human body, and five tones are considered to be communicated with the five zang organs. The theory of five zang organs with the five attributes of wood, fire, earth, gold and water is proposed in the theory of Su Wen & Yin Yang correspondence theory, namely, the spleen is called by uterine sound, the lung is called by commercial sound, the liver is called by horn sound, and the heart and feather are called by feather sound. Modern researches have shown that the volume of microcirculation around acupoints of meridians and collaterals can be changed differently under the stimulation of sound waves of different frequencies, and the phenomenon of resonance of the sound waves with qi and blood of meridians and collaterals is completely identical to the theory of five sounds corresponding to five internal organs in Huangdi's inner meridian. The treatment is carried out according to the midnight-noon ebb-flow rule by the five-tone therapy of the traditional Chinese medicine. The midnight-noon ebb-flow is divided into twelve hours each day corresponding to twelve earthly branches. It is combined with the circulation of qi and blood of the twelve zang-fu organs and the opening and closing of the five acupoints. In twelve hours of the day, the qi and blood of the human body circulate and flow together from head to tail, and there are rhythm and time phase characteristics when the qi and blood are fully opened or closed. The five-tone therapy is an important way for the development of the five-tone therapy, and combines the dual advantages of the midnight-noon ebb-flow and the five-tone therapy, so that the five-tone therapy has more obvious curative effect.

In order to enable the insomnia treatment apparatus 100 to more intelligently treat insomnia of a user, eliminate the psychological sense of the user intentionally performing treatment, make the treatment process of the user more natural and comfortable, help the user to insist on long-term treatment, and help the user to maintain on-time treatment, thereby improving the effect of insomnia treatment, please refer to fig. 2 and fig. 3, fig. 3 is a schematic front structure diagram of the insomnia treatment apparatus 100, in this embodiment, the insomnia treatment apparatus 100 further includes the following structures:

the system comprises a singlechip 102, a liquid crystal display 104, an illumination sensor 106 and a clock module (not shown in the figure, in the embodiment, a DS3231 clock module is used). The single chip microcomputer 102 is used for controlling the sleep drug releasing component 110 to be started or closed; the single chip microcomputer 102 is used for controlling the sleep music playing component 150 to be started or closed. The clock module is used for acquiring the current time and displaying the current time on the liquid crystal display screen 104. The single chip microcomputer 102 selects a song played by the sleep music playing component 150 according to the time information acquired from the clock module, and displays the information of the song on the liquid crystal display 104.

Referring to fig. 4, fig. 4 is a main control circuit diagram of the single chip microcomputer 102. The single chip microcomputer 102 is a control center of the whole drug release and music playing system, and controls each sub-function module to work coordinately, so that all functions of the whole intelligent system are completed. The intelligent system selects an ATmega328P singlechip with low price and reliable performance, and compared with 8051 series singlechips, the ATmega328P singlechip has higher main frequency and larger storage capacity. Another feature of ATmega328P is the ability to operate in a low power mode, with an option for idle mode and power down mode. In the power-down mode, the clock is stopped, the ROM data is not lost, and other functions are stopped simultaneously; in the idle mode, the RAM, serial port, timer and interrupt system can still work normally although the CPU stops working. These features of ATmega328P become the preferred single chip for many embedded control applications. In this embodiment, the No. 6 pin and the No. 4 pin are both connected to 5V voltage, the No. 18 pin is connected to a capacitor, and the No. 3, No. 5, and No. 21 pins are all grounded.

Referring to FIG. 5, FIG. 5 is a circuit diagram of an LCD module according to the IIC protocol. The IIC bus is a serial bus formed by the data line SDA and the clock signal line SLC, and can transmit and receive data. The IIC bus shares three types of signals in the process of transmitting data, which are respectively: a start signal, an end signal and a response signal. Start signal: when SCL is high, SDA transitions from high to low to begin transmitting data. An end signal: when SCL is high level, SDA jumps from low level to high level to finish transmitting data. Response signal: after receiving 8-bit data, the IC receiving the data sends a specific low-level pulse to the IC transmitting the data, indicating that the data has been received. After the single chip sends a signal to the controlled unit, the single chip waits for the controlled unit to send a response signal, and after the single chip receives the response signal, the single chip judges whether to continuously transmit the signal according to the actual condition. If the answer signal is not received, the controlled unit is judged to be in fault. The liquid crystal display is selected as the output state display in the intelligent atomization and Schle system, and has the following advantages that the display parameters are stable and do not flicker, which is determined by the unique display principle of the liquid crystal display; the 1602 character type liquid crystal display is selected in the intelligent system, so that the intelligent system is light in weight, small in size and convenient to integrate and miniaturize; the liquid crystal display selected in the system is a digital interface, so that the liquid crystal display and a control interface of the singlechip 102 are simpler and more reliable, and the operation is more convenient; the liquid crystal display is selected in the system, and the adjustment is convenient for users. The liquid crystal display displays contents in a direct addressing mode, so that a user can adjust the screen of the liquid crystal display more conveniently; the power consumption of the liquid crystal display is low, and the energy consumption of the liquid crystal display selected by the system is mainly used for the consumption of the internal electrode and the driving of the IC, so the power consumption is less than that of the traditional display. For the above reasons and advantages, the 1602 character type LCD is selected for the system.

The sleep drug delivery assembly 110 includes an ultrasonic nebulizer. The illumination sensor 106 collects the intensity of ambient light, the digital signal is transmitted to the single chip microcomputer 102 through an IIC communication protocol after analog-to-digital conversion, and the single chip microcomputer 102 judges whether the ultrasonic atomizer is started to atomize the liquid medicine under the current condition according to the preset light intensity. Referring to fig. 6, fig. 6 is a circuit diagram of an analog-to-digital conversion module of PCF 8591. The analog-digital conversion module PCF8591 selected in the intelligent atomization and Schle system is a single integrated, low-power-consumption and independent power supply module. PCF8591 has 4 analog inputs, 1 analog output, and 1 serial IIC bus interface. The 3 address pins a0, a1, and a2 of PCF8591 may be used for hardware address programming, allowing access to 8 PCF8591 devices on the same IIC bus without additional hardware. Address, control, and data signals input and output on the PCF8591 device are transmitted serially over the two-wire bi-directional IIC bus. In the system, a data transmission port and a control port which are connected with the singlechip 102 on the PCF8591 device are transmitted in a serial mode. The start signal of the digital-to-analog conversion module is sent by the single chip microcomputer 102, and the occupation condition of the bus needs to be detected before the single chip microcomputer 102 sends the data transmission signal. If the bus is in an idle state, a data transmission signal can be sent out to carry out data transmission. The digital-to-analog conversion module selected in the system can supply power independently (the voltage range is 2.5-6.0V), and has the advantages of low standby current and the like.

The ultrasonic nebulizer is provided with a drug solution cartridge 112 and a level sensor (not shown in fig. 2) for detecting the remaining amount of drug solution in the drug solution cartridge 112. The singlechip 102 controls the ultrasonic atomizer to start alarm or stop alarm according to the detection result of the liquid level sensor. When the residual amount of the liquid medicine is lower than the preset liquid medicine amount, the singlechip 102 controls the ultrasonic atomizer to start alarming, and when the residual amount of the liquid medicine is higher than the preset liquid medicine amount, the singlechip 102 controls the ultrasonic atomizer to stop alarming. The ultrasonic atomizer further includes an atomizing plate 111 and an atomizing tube 113.

The ultrasonic atomizer utilizes electronic high-frequency oscillation (oscillation frequency is 1.7MHz or 2.4MHz, which exceeds the human auditory range and has no harm to human bodies and animals), breaks up the liquid molecular structure through the high-frequency resonance of the ceramic atomizing sheet 111 to generate natural and elegant tiny fog particles without heating or adding any chemical reagent. Ultrasonic wave can atomize water-soluble medicines (as long as the water-soluble medicines are available, no other special requirements) into 1-5 um micro fog particles at normal temperature, water is used as a medium, water-soluble liquid medicine is sprayed into fog by utilizing ultrasonic directional pressure, and the liquid medicine is sprayed into an airway of a patient by virtue of wind power of an internal fan and then is inhaled by the patient. Compared with the heating atomization mode, the energy is saved by 90 percent (of course, the mode of heating to release the medicine can be adopted in other embodiments). In addition, a large amount of negative ions are released in the atomization process and generate electrostatic reaction with smoke, dust and the like floating in the air, so that the negative ions are precipitated, and meanwhile, harmful substances such as formaldehyde, carbon monoxide, bacteria and the like can be effectively removed, so that the air is purified, and the occurrence of diseases is reduced. The ultrasonic atomizer has the advantages of simple structure, convenient use, stable treatment effect, no pain, small side effect of the medicine, low cost and the like.

The cartridge 112 is provided with a feed tube 114 (see fig. 2), and the feed tube 114 is provided with a feed valve (not shown). And the feed valve is a one-way valve in this embodiment. The volume of the liquid medicine box 112 is 85ml, for example, when the solution in the liquid medicine box 112 is less than 10% (volume) (i.e. when the liquid medicine box reaches the pre-warning position), the single chip microcomputer 102 controls the ultrasonic atomizer to give an instruction (i.e. turn on the alarm) for adding liquid medicine. The one-way valve allows the liquid medicine to enter the liquid medicine box 112 and not to overflow out of the insomnia therapeutic apparatus 100. After receiving the instruction of adding the liquid medicine, the user prepares a liquid medicine bottle (shown in fig. 1) containing the liquid medicine, and squeezes the liquid medicine in the liquid medicine bottle into the liquid medicine box 112 through the one-way valve until the liquid medicine cannot be squeezed into the liquid medicine box 112 continuously, which indicates that the liquid medicine in the liquid medicine box 112 is full, and the addition of the liquid medicine is stopped. Because the feed valve of the liquid medicine box 112 is a one-way valve, even if the liquid medicine box 112 is filled during the liquid adding process, the situation that the liquid medicine overflows from the one-way valve does not occur, and only the situation that the liquid medicine cannot be continuously extruded into the liquid medicine box 112 occurs. Of course, to ensure that the liquid medicine does not overflow the liquid medicine box 112, it is necessary to ensure that the sealing performance around the liquid medicine box 112 is good. The ultrasonic atomizer has the same structure and use considerations as a conventional ultrasonic atomizer except that the configuration of the feed pipe 114 is slightly different from that of the conventional atomizer.

In order to further prevent the liquid medicine in the liquid medicine box 112 from leaking to the single chip microcomputer 102 and the sleep music playing component 150 adjacent thereto, and causing damage to the two, a sealing shell 117 is further arranged outside the liquid medicine box 112.

In order to improve the integrity of the insomnia treatment apparatus 100 and facilitate the use and carrying, the insomnia treatment apparatus 100 further includes a housing 180 (made of any material, in this embodiment, ABS resin is used), and other components are mounted to the housing 180. The shell 180 may further select sky blue as the main color according to the principle that blue can calm people and calm mind and tranquilize mind in color psychology. In fig. 1, it can be observed that the inlet 116 of the inlet tube 114 is exposed from the back of the housing 180, which is convenient for the user to add the liquid medicine. In fig. 1, it can be seen that the spray opening 118 of the atomization tube 113 is exposed from the top of the housing 180, facilitating the ejection of the atomized liquid medicine. As can be observed from fig. 3, the liquid crystal display screen 104 is located on the front surface of the casing 180 and is displayed in a full screen manner, so that a user can observe displayed information more clearly; the illumination sensor 106 is mounted on top of the housing 180; the speakers 152 are exposed from opposite sides of the housing 180 so that the sound emitted has a better stereo surround effect, and only one of the speakers 152 is shown in fig. 3 with one side exposed.

The housing 180 is also provided with a switch button 182, a function button 184, and an earphone jack 186. After the switch button 182 is pressed for a long time, the system is started up, the initialization setting of each module is automatically performed, and the liquid crystal display 104 displays the information of the current time, the current date, the played song, the liquid level of the liquid medicine, the electric quantity and the like. The key center of the short-press function button 184 jumps to the ultrasonic atomization control program. The key center of the double-push function button 184 jumps to the music playing program and the ultrasonic atomization control program at the same time. The left and right buttons of the function button 184 are music switching buttons, the left button of the function button 184 is a play previous button, and the right button of the function button 184 is a play next button. After the long-press switch button 182 is turned on, the short-press switch button 182 can enter the setting of the music playing time length; double-pressing switch button 182 may enter the setting of the nebulization time. After the switch button 182 is pressed again for a long time, the system is turned off.

Referring to fig. 7, fig. 7 is a circuit diagram of the ultrasonic atomization module. The ultrasonic atomizer is controlled by an optical coupling relay, and the relay generally comprises an iron core, a coil, an armature, a contact reed and the like. After the power supply is switched on, an electromagnetic effect is generated, the armature is attracted by the electromagnetic force and is contacted with the iron core, the normally closed electric shock and the normally open contact of the armature are driven to attract, after the current is cut off, the electromagnetic attraction disappears, and the armature returns to the original position to cut off the circuit. The relay can control a circuit with high power by a very small current, and can also enlarge the control range, and when the signal reaches a certain value, the relay can simultaneously change, open and close the multi-way circuit according to different forms of the contact group, thereby achieving the purpose of automatic switching. The singlechip 102 compares the light intensity and other information read by the illumination sensor 106 with a set threshold value, so that the work of the ultrasonic atomizer is controlled by controlling the closing of the relay, and meanwhile, the work of the ultrasonic atomizer can be controlled in time according to the liquid level information read by the liquid level sensor, so that the safety of equipment is ensured.

Referring to fig. 8, fig. 8 is a circuit diagram of the liquid level sensor module. The Water level Sensor is a Water level Sensor of the world news, which determines Water level by measuring the Water drop/volume through a series of exposed parallel wire traces. The conversion from water quantity to analog signals is completed, the analog signals are converted into digital quantity through the ADC, and the digital quantity is read by the singlechip 102.

The sleep music playing module 150 includes a speaker 152, a memory card (not shown), and an MP3 module (not shown). The corner, sign, palace, quotient and feather five-tone songs are stored in the memory card. The MP3 module is used to drive the speaker 152, and the single chip microcomputer 102 is set to play the corresponding song in the corresponding time. Referring to fig. 9, fig. 9 is a circuit diagram of a voice module of the sleep music playing component 150. The MP3 module of TELESKY is adopted in the intelligent atomization and Happy system, the module supports TF card reading and U disk reading, the use of a user is facilitated, meanwhile, a 2W-3W single-channel power amplifier drives a loudspeaker 152, the volume is ensured to be sufficient and adjustable, and meanwhile, the single chip microcomputer 102 can control the playing time and the song.

After the five-tone music is stored, the corresponding relationship between the playing music and the playing time period is preset in the single chip microcomputer 102, for example, as shown in table 1.

TABLE 1 five-tone music and indications

And setting according to the content shown in the table 1, and playing the corresponding track in the corresponding time period. Of course, in other embodiments, other five-tone songs may be selected, for example, the pitch-type songs may also be grass-tree green, and windward; the tuning type songs can be happy meeting and all birds playing the phoenix; the style songs can be autumn lake, moon and night, or bird feeding forest; the commercial tune type song can be Yangguan Sanjian, yellow river Dahe singing; the feather style songs may be shoujun complaints, shangqu.

In other embodiments, the insomnia curing apparatus 100 may further comprise a bluetooth module. The Bluetooth module is a PCBA board integrating the Bluetooth function, is used for short-distance wireless communication, and is divided into a Bluetooth data module and a Bluetooth voice module according to functions. As a short-distance wireless communication technology replacing a data cable, bluetooth supports point-to-point and point-to-multipoint communication, various data and voice devices in a home or office are wirelessly connected into a piconet (Pico-net), and several piconets can be further interconnected to form a distributed network (scatter-net), so that fast and convenient communication is realized among the connected devices. The Bluetooth module is provided with an on-chip digital wireless processor DRP (digital radio processor), a numerical control oscillator, an on-chip radio frequency receiving and transmitting switch, an internal ARM7 embedded processor and the like. The whole system consists of a DSP, a BRF6100, an audio AD/DA, a liquid crystal, a keyboard and a Flash, wherein the DSP is a core control unit, and the audio AD is used for converting collected analog voice signals into digital voice signals; the audio DA converts the digital voice signal into an analog voice signal, and outputs the analog voice signal to an earphone or a speaker. Due to the arrangement of the Bluetooth module, a user can perform signal connection between the mobile phone of the user and the insomnia therapeutic apparatus 100, and the user can control various adjustment and setting operations of the insomnia therapeutic apparatus through the mobile phone.

The insomnia therapeutic apparatus 100 further includes a battery (in this embodiment, a lithium battery 18650) and an electric quantity indicating lamp set 108 for displaying the remaining electric quantity of the battery. Lithium battery 18650 has light in weight, and capacity is big, advantages such as no memory effect, and satisfies the long-time stable use of equipment. 18650 rechargeable lithium battery is responsible for the power supply work of insomnia therapeutic apparatus 100, can realize many times and charge and discharge the function, and the user can charge at USB socket 107 of insomnia therapeutic apparatus 100 back below by oneself. In fig. 1, it can be observed that the USB socket 107 is exposed from the back of the housing 180, which facilitates external charging; a power indicator light 108 is also mounted on the back of the housing 180 adjacent to the USB socket 107. The sleep drug releasing component 110 and the sleep music playing component 150 are electrically connected with the storage battery. When the remaining capacity of the battery is greater than the first preset value, the capacity indicating lamp set 108 turns on a green lamp. When the remaining capacity of the battery is less than the second preset value, the capacity indicating lamp set 108 lights up a red light. When the remaining power of the battery is a third preset value, the power prompt lamp set 108 lights up a yellow lamp. Wherein the second preset value is more than 0 percent and less than or equal to the third preset value and less than or equal to the first preset value and less than 100 percent. In this embodiment, when the remaining capacity of the battery is greater than 80%, the green light is turned on; when the residual electric quantity of the storage battery is less than 10%, the red light is turned on; when the residual electric quantity of the storage battery is 10% -80%, the yellow lamp is turned on. The storage battery is a 570mAh battery, and provides long endurance for the atomization function and the music playing function. The atomization and the music playing are started simultaneously for about 32 hours; only starting atomization or only starting music playing for about 50 hours; the red light may continue to be used for about 5 hours when it is on.

Referring to fig. 10, fig. 10 is a general circuit diagram of the insomnia therapeutic apparatus 100. The reset circuit provides a reset signal for the singlechip 102, and the system is reset and started again through the key after the system is started; the clock circuit provides a clock signal for the singlechip 102, namely a beat of code operation; the key circuit sets parameters of the system through keys, including setting keys and adding and subtracting keys; the liquid crystal display circuit is provided with 8 data ports and 3 time sequence ports, the backlight of the liquid crystal can be adjusted through a potentiometer, and a pull-up resistor is connected to the P0 port because the inside of the port is not pulled up; the reed pipe circuit detects the water level by a high-low level signal; the atomization relay circuit is driven by a PNP triode, and an LED3 diode performs an indicating function (the relay is turned on after being closed); the analog-digital/digital-analog conversion circuit acquires data of the photoresistor sensor through analog-digital conversion and outputs analog quantity through a digital-analog conversion channel; the speaker 152 circuit is driven by a triode.

Referring to fig. 11, fig. 11 is a flow chart showing the use design of the insomnia therapeutic apparatus 100. After the mobile phone is started, the initialization setting of each module is advanced, and the current time and the current working mode are displayed (similar to the principle that the time of the mobile phone is correspondingly adjusted to the current correct time after the mobile phone is started). After the program is started, the program circularly detects whether a key is pressed down, and enters a corresponding interrupt and subprogram when a certain key is detected to be started. A keyboard input program for detecting whether a key is pressed down or not, and skipping if the key is pressed down; a function transfer program, which judges the detected key value, jumps to the music playing program when the key is pressed for a long time, jumps to the ultrasonic atomization control program when the key is pressed for a short time, jumps to the music playing program and the ultrasonic atomization control program when the key is pressed for a double time, and regulates and controls the size of the loudspeaker 152 when the key is pressed up and down; a light intensity detection program for detecting the intensity of ambient light, and skipping to an ultrasonic atomization program when no light exists; ultrasonic atomization procedure, namely atomizing the liquid medicine solution into gas, and automatically closing the gas when preset time is reached; the music playing program can automatically identify the specific time and play the specific music, and can also be set to be automatically closed when the preset time is reached. Because the start of the ultrasonic atomizer is automatically controlled by the light intensity, the light intensity is weakened at night, the ultrasonic atomizer is automatically started, but if the lighting effect is not good in a room in the daytime, the atomizer can be started by mistake. Therefore, in order to more accurately control the starting of the atomizer under the condition that the light intensity is weakened at night, before the ultrasonic atomizer is started, whether the current time is the night time (generally 20:00-5:00) needs to be determined through the time signal, and if the current time is the night time, the starting of the atomizer is confirmed through the acquisition of the light intensity. Meanwhile, in order to facilitate that a user who needs sleep and rest in the daytime can conveniently control the starting of the atomizer, when the user presses the key center of the function button 184 in the daytime, the user can enter the setting of the atomization time, and after the setting of the atomization time is completed, the atomizer is automatically started to help the user to sleep.

The insomnia treatment instrument 100 is used for insomnia treatment and mainly comprises the following steps:

the drug released by the sleep drug releasing assembly 110 is volatile oil in rhizome of Acorus gramineus, and when the user wants to sleep, the sleep drug releasing assembly 110 releases the liquid drug to the surrounding environment in a gaseous state. In this embodiment, the single chip microcomputer 102 controls whether the ultrasonic atomizer atomizes according to the detection result of the illumination sensor 106. The software design adopts a light intensity detection program to detect the intensity of ambient light, and the software jumps to an ultrasonic atomization program when no light exists; after the ultrasonic atomization program is started, atomizing the rhizoma acori graminei volatile oil solution into gas, and automatically closing after the preset atomization time is reached.

The sleep music playing component 150 selects a set song from the corner, the dog, the house, the quotient and the quince songs for playing within a set time period. The music playing program automatically identifies specific time and plays specific music, and when the preset time is reached, the music is automatically closed or replaced, so that the music playing program is more automatic and intelligent. The relevant songs of the corner, the sign, the palace, the quotient and the feather five tones are collected and stored in the TF card, the MP3 module is adopted to drive the loudspeaker 152, and the singlechip 102 selects the played songs according to the set time.

The release of the drug and the playing of the song can be carried out simultaneously or separately.

The release of the medicine is carried out for 1-3 times per day, the release time is 25-35 minutes each time, the volume is not too large when the music is played, and the volume is 40-60 decibels.

The insomnia therapeutic apparatus 100 has the working principle that:

the insomnia therapeutic apparatus 100 provided by this embodiment makes full use of the performance advantages of the single chip microcomputer 102 in the field of embedded control, realizes functions such as intelligent detection and automatic control, ensures real-time reliability of the system, and has higher control precision, thereby improving intelligence and stability of the ultrasonic atomizer, and improving the effect of treating patients to the greatest extent. The insomnia therapeutic apparatus 100 adopts an ATmega328P singlechip, and has low price and reliable performance; the 1602 character type liquid crystal display screen 104 is selected, so that the system is light in weight and small in size, and is convenient to integrate and miniaturize; the selected digital-to-analog conversion module PCF8591 is a single integrated, low-power-consumption and independent power supply module; a DS3231 high-precision clock module of Risym is adopted, the module has the precision of 2ppm, small error and high precision; an MP3 module of TELESKY is adopted, and the module supports TF card reading and U disk reading, so that the use of a user is facilitated; the Water level Sensor of the modern is adopted, the module has high precision and good sensitivity, and can accurately detect the Water level so as to supplement the solution in time; the lithium battery 18650 is selected, so that the device has the advantages of light weight, large capacity, no memory effect and the like, and can be stably used for a long time.

The acorus gramineus volatile oil solution is atomized by an ultrasonic atomization technology and the singlechip 102 music playing technology is timely happy, so that the effects of relieving depression, helping sleep, calming the heart, soothing the nerves and balancing yin and yang are achieved, and the effect of treating insomnia is achieved. Aromatherapy, pentatherapy, modern ultrasonic atomization and music playing of the singlechip 102. The music is played while the aromatic nerve-soothing traditional Chinese medicine is atomized, so that the use comfort is better. The insomnia therapeutic apparatus 100 is convenient to operate and easy to carry, and is more beneficial to long-term use by patients. Compared with the five-tone treatment and the traditional Chinese medicine or ointment conditioning in hospitals, the sleep treatment saves time cost and economic cost.

The above is only a preferred embodiment of the present invention, and is not intended to limit the present invention, and various modifications and changes will occur to those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. The insomnia therapeutic apparatus is characterized by comprising a sleep medicine releasing component and a sleep music playing component, wherein the sleep medicine releasing component and the sleep music playing component are matched with each other to achieve the effect of treating insomnia, the sleep music playing component comprises a single chip microcomputer, the sleep medicine releasing component comprises an ultrasonic atomizer, the ultrasonic atomizer comprises a liquid medicine box for storing medicines, and the ultrasonic atomizer is provided with a liquid level sensor for detecting the liquid medicine allowance in the liquid medicine box.

2. The insomnia therapeutic apparatus according to claim 1, wherein the single chip microcomputer is configured to control the sleep drug releasing component to be turned on or off; the single chip microcomputer is used for controlling the sleep music playing component to be started or closed.

3. The insomnia therapeutic apparatus according to claim 1, wherein the ultrasonic nebulizer is adapted to nebulize the liquid medicine stored therein.

4. The insomnia treatment apparatus of claim 1, wherein said drug solution box is provided with a feed tube, said feed tube being provided with a feed valve.

5. The insomnia therapy apparatus of claim 4, wherein said inlet valve is a one-way valve.

6. The insomnia therapeutic apparatus according to claim 1, wherein the single chip microcomputer controls the ultrasonic atomizer to start an alarm or stop the alarm according to the detection result of the liquid level sensor.

7. The insomnia treatment apparatus according to claim 2, wherein the insomnia treatment apparatus further comprises a light sensor, and the single chip microcomputer controls the sleep drug release assembly to be turned on or off according to a detection result of the light sensor.

8. The insomnia therapeutic apparatus of claim 1, wherein said sleep music playing module comprises a speaker.

9. The insomnia therapeutic apparatus according to any one of claims 1-8, further comprising a housing, wherein the housing is provided with a display screen for displaying time, date, liquid level information of the remaining amount of the liquid medicine in the sleep drug releasing component and playing track information of the sleep music playing component, and the sleep drug releasing component and the sleep music playing component are both located in the housing.

10. The apparatus according to any one of claims 1-8, wherein the drug released from the sleep drug releasing assembly comprises acorus gramineus, and the music stored in the sleep music playing assembly comprises songs of horn, monument, palace, quotient, quincunx.